Glutathione-S-transferase T1 and M1 gene polymorphisms in Greek patients with multiple sclerosis: A pilot study

European Journal of Neurology

Volumn 14, Issue 5, 2007, Pages 572-574

  Stavropoulou, C ^a   Korakaki, D ^b   Rigana, H ^a   Voutsinas, G ^a   Polyzoi, M ^b   Georgakakos, V N ^a   Manola, K N ^a   Karageorgiou, C E ^b   Sambani, C ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

Author keywords

Detoxification; GSTM1; GSTT1; Multiple sclerosis; Null genotype; Susceptibility

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISABILITY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE DELETION; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUTATHIONE TRANSFERASE M1 GENE; GLUTATHIONE TRANSFERASE T1 GENE; GREECE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM; DNA MUTATIONAL ANALYSIS; FEMALE; FREE RADICAL SCAVENGERS; GENETIC MARKERS; GENETIC SCREENING; GENOTYPE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; GREECE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OXIDATIVE STRESS; PILOT PROJECTS; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; SEX DISTRIBUTION;

EID: 34247135394     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2006.01678.x     Document Type: Article

References (13)

1. Gilgun-Sherki Y, Melamed E, Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. Journal of Neurology 2004; 251: 261-268.
2. Ketterer B, Coles B, Meyer DJ. The role of glutathione in detoxification. Environmental Health Perspectives 1983; 49: 55-69.
3. Garder PJ, Hume R, Fryer AA, Strange RC, Lauder J, Bell JE. Glutathione S-transferase in human brain. Neuropathology and Applied Neurobiology 1990; 16: 293-303.
4. Seidegard J, Vorachek WR, Pero RW, Pearson WR. Hereditary differences in the expression of the human glutathione transferase active in trans-stilbene oxide are due to a gene deletion. Proceedings of the National Academy of Sciences of the United States of America 1998; 85: 7293-7297.
5. Garte S, Gaspari L, Alexandrie AK, et al. Metabolic gene polymorphism frequencies in control populations. Cancer epidemiology, Biomarkers & Prevention 2001; 10: 1239-1248.
6. Li YJ, Oliveira SA, Xu P, et al. Glutathione S-transferase omega 1 modifies age-at-onset of Alzheimer and Parkinson disease. Human Molecular Genetics 2003; 12: 3259-3267
7. De Palme G, Mozzoni P, Mutti A, Calzetti S, Negrotti A. Case-control study of interactions between genetic and environmental factors in Parkinson's disease. Lancet 1998; 352: 1986-1987.
8. Stroombergen MC, Waring RH. Determination of glutathione S-transferase mu and theta polymorphisms in neurological disease. Human and Experimental Toxicology 1999; 18: 141-145.
9. Söderkvist P, Ahmadi A, Åkerback A, Axelson O, Flodin U. Glutathione S-transferase M1 null genotype as a risk modifier for solvent-induced chronic toxic encephalopathy. Scandinavian Journal of Work, Environment & Health 1996; 22: 360-363.
10. Mann CL, Davies MB, Boggild MD, et al. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Neurology 2000; 54: 542-544.
11. Poser C, Paty D, Scheinberg L, McDonald WI, Davies FA, Ebers GC. New diagnostic criteria for multiple sclerosis. Annals of Neurology 1983; 13: 227-231.
12. Whitacre CC, Reingold SC, O'Looney PA. A gender gap in autoimmunity. Science 1999; 283: 1277-1278.
13. Voskuhl RR. Gender issues and multiple sclerosis. Current Neurology and Neuroscience Reports 2002; 2: 277-286.